{"version":"1.0","provider_name":"IRLAB","provider_url":"https:\/\/irlab.se\/sv\/","title":"IRLAB Therapeutics del\u00e5rsrapport jan-mars 2017 - IRLAB","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HVRLykCrGN\"><a href=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-therapeutics-delarsrapport-jan-mars-2017\/\">IRLAB Therapeutics del\u00e5rsrapport jan-mars 2017<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/irlab.se\/sv\/mfn_news\/irlab-therapeutics-delarsrapport-jan-mars-2017\/embed\/#?secret=HVRLykCrGN\" width=\"600\" height=\"338\" title=\"\u201dIRLAB Therapeutics del\u00e5rsrapport jan-mars 2017\u201d &ndash; IRLAB\" data-secret=\"HVRLykCrGN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/irlab.se\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"[mfn_before_post] 1 januari \u2013 31 mars 2017 i korthet R\u00f6relseresultatet uppgick till \u20139 889 TSEK (\u201314 033 TSEK). Periodens resultat uppgick till \u201311 894 TSEK (\u201310 961 TSEK). Resultatet per aktie f\u00f6re och efter utsp\u00e4dning h\u00e4nf\u00f6rligt till moderbolagets aktie\u00e4gare uppgick till -1,98 SEK (-2,53 SEK). Likvida medel per den 31 mars 2017 uppgick till 120 [&hellip;]"}